Fibrosarcoma

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) [Phase 1, Phase 2]

  This is a clinical trial protocol update for NRSTS2021, a Phase 1/2 study evaluating maintenance pazopanib, limited-margin radiation therapy…

• CLINICAL_TRIALS research · 2026-02-06
  Clinical Trial Update: A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning [NA]

  A clinical study sponsored by Ricoh USA, Inc. is evaluating the use of 3D-printed models to assist pre-operative planning for various sarcom…

• CLINICAL_TRIALS research · 2026-01-08
  Clinical Trial Update: IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) [Phase 2]

  Phase 2 trial evaluating an immuno-oncology combination as first-line treatment for soft tissue sarcomas; currently recruiting.

• CLINICAL_TRIALS trial_result · 2024-10-29
  Clinical Trial Update: Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies

  This clinical trial update reports results comparing infantile fibrosarcoma with adult-type fibrosarcoma. It also assesses the risk of devel…

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

  Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-12-27
  Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]

  A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…

• CLINICAL_TRIALS trial_result · 2017-05-19
  Clinical Trial Update: Bevacizumab and Radiation Therapy for Sarcomas [Phase 2]

  Phase 2 trial evaluating bevacizumab with radiation therapy in soft tissue sarcomas completed, with results posted in 2017.

• CLINICAL_TRIALS trial_result · 2017-05-12
  Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]

  Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results po…

• CLINICAL_TRIALS research · 2016-05-17
  Clinical Trial Update: Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

  A completed clinical trial update studying gene expression in tissue samples from children and adolescents with soft tissue sarcomas to bett…

• CLINICAL_TRIALS trial_result · 2015-07-30
  Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

  A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…

• CLINICAL_TRIALS trial_result · 2015-03-31
  Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma [Phase 2]

  Phase 2 trial evaluating cixutumumab with temsirolimus in pediatric patients with recurrent or refractory sarcomas has been completed with r…

• CLINICAL_TRIALS trial_result · 2014-10-02
  Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]

  Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…

• CLINICAL_TRIALS trial_result · 2014-06-20
  Clinical Trial Update: Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers [Phase 2]

  This Phase 2 trial evaluates high-dose chemotherapy with bone marrow or stem cell transplant for rare poor-prognosis cancers. The study incl…

• CLINICAL_TRIALS trial_result · 2013-11-26
  Clinical Trial Update: Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma [Phase 2]

  A Phase 2 trial evaluating surgery and/or chemotherapy for pediatric fibrosarcoma (infantile/congenital/childhood) was terminated, with resu…

• CLINICAL_TRIALS trial_result · 2013-11-08
  Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]

  Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.

• CLINICAL_TRIALS trial_result · 2013-02-28
  Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans [Phase 2]

  Phase 2 trial evaluating imatinib mesylate in patients with locally recurrent or metastatic dermatofibrosarcoma protuberans.

• CLINICAL_TRIALS trial_result · 2012-08-28
  Clinical Trial Update: Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma [Phase 2]

  Phase II trial results for sunitinib malate in metastatic or surgically unresectable soft tissue sarcoma were posted, evaluating activity ac…

• EMA guidance · 2007-07-19
  European Medicines Agency holds Focus Group meeting on fibrosarcoma occurring at sites of injection of veterinary medicines in cats

  EMA reports a focused discussion on fibrosarcoma occurring at injection sites in cats treated with veterinary medicines, highlighting safety…